Why Does The Stock Of Cigna (CI) Look Attractive Now?
Zacks Investment Research | Jan 09, 2019 09:25PM ET
The stock of Cigna Corp. (NYSE:CI) has seen the Zacks Consensus Estimate for current-year earnings being revised 7.2% upward over the last seven days. This shows analysts’ optimism over Cigna, which recently closed the acquisition of Express Scripts (NASDAQ:ESRX), the pharmacy benefit manager, which will transform it into a diversified health services company.
The addition of Express Scripts will provide a nice diversification to the company’s existing businesses — administrative services, international operations, and disability and life insurance — which are already performing strongly.
The combination of Express Scripts’ pharmacy benefit business with Cigna’s health insurance business, will help control drug pricing cost to a large extent, one of the biggest components of soaring medical cost. Cigna anyway has a better control over its medical cost than other players in the industry. The decline in medical costs should further aid its margins.
Another distinguishing feature of the company is its international business, which provides additional diversification opportunities. Cigna’s international business, which includes India, Hong Kong, Turkey and the Middle East, among others, has overall recorded double-digit revenue and earnings growth for the past seven years. The biggest international market for Cigna is South Korea, where it has been operating for more than three decades.
Moreover, the company has a large chunk of revenues coming from the administrative services only (ASO) business, which though has lower profitability, is growing in size and provides opportunities for cross selling.
Another positive for Cigna is its strong capital position. Its cash flow from operations has been increasing consistently for the past four years and the trend continued in the first nine months of 2018. An increasing cash flow provides scope for investment in business. Though the company’s leverage levels have increased due to the purchase of Express Scripts, the same should moderate by next year as the company repays debt.
Cigna expects adjusted EPS in 2019 to gain in the double-digits range (this excludes any impact from transitioning of clients by Express Scripts specially Anthem (NYSE:ANTM)). By the year 2021, Cigna projects adjusted EPS of $20 to $21, of which $2 to $3 will come from Express Scripts.
In a year's time, the stock has lost 8.1% compared with the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.